Works matching IS 03407004 AND DT 2020 AND VI 69 AND IP 7

Results: 21

Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1327, doi. 10.1007/s00262-020-02550-7

By:

Li, Ruochen;
Zhang, Heng;
Cao, Yifan;
Liu, Xin;
Chen, Yifan;
Qi, Yangyang;
Wang, Jieti;
Yu, Kuan;
Lin, Chao;
Liu, Hao;
He, Hongyong;
Li, He;
Chen, Lingli;
Shen, Zhenbin;
Qin, Jing;
Zhang, Weijuan;
Sun, Yihong;
Xu, Jiejie

Publication type:

Article

Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.

Published in:

2020

By:

Naqash, Abdul Rafeh;
Ricciuti, Biagio;
Owen, Dwight H.;
Florou, Vaia;
Toi, Yukihiro;
Cherry, Cynthia;
Hafiz, Maida;
De Giglio, Andrea;
Muzaffar, Mavish;
Patel, Sandip H.;
Sugawara, Shunichi;
Burkart, Jarred;
Park, Wungki;
Chiari, Rita;
Sugisaka, Jun;
Otterson, Gregory A.;
de Lima Lopes, Gilberto;
Walker, Paul R.

Publication type:

Correction Notice

Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1293, doi. 10.1007/s00262-020-02546-3

By:

Bi, Guoshu;
Chen, Zhencong;
Yang, Xiaodong;
Liang, Jiaqi;
Hu, Zhengyang;
Bian, Yunyi;
Sui, Qihai;
Li, Runmei;
Zhan, Cheng;
Fan, Hong

Publication type:

Article

A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1353, doi. 10.1007/s00262-020-02552-5

By:

Orth, Martin F.;
Buecklein, Veit Leonhard;
Kampmann, Eric;
Subklewe, Marion;
Noessner, Elfriede;
Cidre-Aranaz, Florencia;
Romero-Pérez, Laura;
Wehweck, Fabienne Sophie;
Lindner, Lars;
Issels, Rolf;
Kirchner, Thomas;
Altendorf-Hofmann, Annelore;
Grünewald, Thomas G. P.;
Knösel, Thomas

Publication type:

Article

TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1315, doi. 10.1007/s00262-020-02549-0

By:

Dadiani, Maya;
Necula, Daniela;
Kahana-Edwin, Smadar;
Oren, Nino;
Baram, Tamir;
Marin, Irina;
Morzaev-Sulzbach, Dana;
Pavlovski, Anya;
Balint-Lahat, Nora;
Anafi, Liat;
Wiemann, Stefan;
Korner, Cindy;
Gal-Yam, Einav Nili;
Avivi, Camila;
Kaufman, Bella;
Barshack, Iris;
Ben-Baruch, Adit

Publication type:

Article

Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1307, doi. 10.1007/s00262-020-02548-1

By:

Farschtschi, Said;
Kluwe, Lan;
Park, Su-Jin;
Oh, Su-Jun;
Mah, Nancy;
Mautner, Victor-Felix;
Kurtz, Andreas

Publication type:

Article

In vivo anti-MUC1+ tumor activity and sequences of high-affinity anti-MUC1-SEA antibodies.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1337, doi. 10.1007/s00262-020-02547-2

By:

Pichinuk, Edward;
Chalik, Michael;
Benhar, Itai;
Ginat-Koton, Ravit;
Ziv, Ravit;
Smorodinsky, Nechama I.;
Haran, Gabi;
Garbar, Christian;
Bensussan, Armand;
Meeker, Alan;
Guillaume, Thierry;
Rubinstein, Daniel B.;
Wreschner, Daniel H.

Publication type:

Article

Lymphocyte activation gene 3 (LAG3) protein expression on tumor-infiltrating lymphocytes in aggressive and TP53-mutated salivary gland carcinomas.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1363, doi. 10.1007/s00262-020-02551-6

By:

Arolt, Christoph;
Meyer, Moritz;
Ruesseler, Vanessa;
Nachtsheim, Lisa;
Wuerdemann, Nora;
Dreyer, Thomas;
Gattenlöhner, Stefan;
Wittekindt, Claus;
Buettner, Reinhard;
Quaas, Alexander;
Klussmann, Jens Peter

Publication type:

Article

Tumor immune microenvironment in cancer patients with leukocytosis.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1265, doi. 10.1007/s00262-020-02545-4

By:

Kim, Kyung Hwan;
Sim, Nam Suk;
Chang, Jee Suk;
Kim, Yong Bae

Publication type:

Article

Predictive value of serum VEGF levels for elderly patients or for patients with poor performance status receiving anti-PD-1 antibody therapy for advanced non-small-cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1229, doi. 10.1007/s00262-020-02539-2

By:

Shibaki, Ryota;
Murakami, Shuji;
Shinno, Yuki;
Matsumoto, Yuji;
Yoshida, Tatsuya;
Goto, Yasushi;
Kanda, Shintaro;
Horinouchi, Hidehito;
Fujiwara, Yutaka;
Yamamoto, Nobuyuki;
Yamamoto, Noboru;
Ohe, Yuichiro

Publication type:

Article

Regulatory T cells specifically suppress conventional CD8αβ T cells in intestinal tumors of APCMin/+ mice.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1279, doi. 10.1007/s00262-020-02540-9

By:

Szeponik, Louis;
Akeus, Paulina;
Rodin, William;
Raghavan, Sukanya;
Quiding-Järbrink, Marianne

Publication type:

Article

Correction to: Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients.

Published in:

2020

By:

Battaglia, Alessandra;
Buzzonetti, Alexia;
Fossati, Marco;
Scambia, Giovanni;
Fattorossi, Andrea;
Madiyalakan, Madi R.;
Mahnke, Yolanda D.;
Nicodemus, Christopher

Publication type:

Correction Notice

Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1177, doi. 10.1007/s00262-020-02536-5

By:

Naqash, Abdul Rafeh;
Ricciuti, Biagio;
Owen, Dwight H.;
Florou, Vaia;
Toi, Yukihiro;
Cherry, Cynthia;
Hafiz, Maida;
De Giglio, Andrea;
Muzaffar, Mavish;
Patel, Sandip H.;
Sugawara, Shunichi;
Burkart, Jarred;
Park, Wungki;
Chiari, Rita;
Sugisaka, Jun;
Otterson, Gregory A.;
de Lima Lopes, Gilberto;
Walker, Paul R.

Publication type:

Article

Adenosine-producing regulatory B cells in head and neck cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1205, doi. 10.1007/s00262-020-02535-6

By:

Jeske, Sandra S.;
Brand, Matthias;
Ziebart, Andreas;
Laban, Simon;
Doescher, Johannes;
Greve, Jens;
Jackson, Edwin K.;
Hoffmann, Thomas K.;
Brunner, Cornelia;
Schuler, Patrick J.

Publication type:

Article

Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1191, doi. 10.1007/s00262-020-02534-7

By:

Voloshin, Tali;
Kaynan, Noa;
Davidi, Shiri;
Porat, Yaara;
Shteingauz, Anna;
Schneiderman, Rosa S.;
Zeevi, Einav;
Munster, Mijal;
Blat, Roni;
Tempel Brami, Catherine;
Cahal, Shay;
Itzhaki, Aviran;
Giladi, Moshe;
Kirson, Eilon D.;
Weinberg, Uri;
Kinzel, Adrian;
Palti, Yoram

Publication type:

Article

Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette–Guérin therapy for non-muscle invasive bladder cancer.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1155, doi. 10.1007/s00262-020-02533-8

By:

Shiota, Masaki;
Fujimoto, Naohiro;
Yamamoto, Yoshiaki;
Takeuchi, Ario;
Tatsugami, Katsunori;
Uchiumi, Takeshi;
Matsuyama, Hideyasu;
Eto, Masatoshi

Publication type:

Article

Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1237, doi. 10.1007/s00262-020-02530-x

By:

Tronik-Le Roux, Diana;
Sautreuil, Mathilde;
Bentriou, Mahmoud;
Vérine, Jérôme;
Palma, Maria Belén;
Daouya, Marina;
Bouhidel, Fatiha;
Lemler, Sarah;
LeMaoult, Joel;
Desgrandchamps, François;
Cournède, Paul-Henry;
Carosella, Edgardo D.

Publication type:

Article

Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1217, doi. 10.1007/s00262-020-02519-6

By:

Teck, Anja Tatjana;
Urban, Sabrina;
Quass, Petra;
Nelde, Annika;
Schuster, Heiko;
Letsch, Anne;
Busse, Antonia;
Walz, Juliane Sarah;
Keilholz, Ulrich;
Ochsenreither, Sebastian

Publication type:

Article

Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approach.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1165, doi. 10.1007/s00262-020-02516-9

By:

Globerson Levin, Anat;
Kronik, Natalie;
Shiloach, Tamar;
Waks, Tova;
Eshhar, Zelig;
Vainstein, Vladimir

Publication type:

Article

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1375, doi. 10.1007/s00262-020-02496-w

By:

Wang, Qian-Ting;
Nie, Ying;
Sun, Sheng-Nan;
Lin, Tao;
Han, Ru-Jin;
Jiang, Jun;
Li, Zhe;
Li, Jun-Qi;
Xiao, Yun-Peng;
Fan, Yu-Ying;
Yuan, Xiao-Hui;
Zhang, Hui;
Zhao, Bin-Bin;
Zeng, Ming;
Li, Shi-You;
Liao, Hua-Xin;
Zhang, Jian;
He, You-Wen

Publication type:

Article

Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes.

Published in:

Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1253, doi. 10.1007/s00262-019-02465-y

By:

Zahran, Asmaa M.;
Hetta, Helal F.;
Rayan, Amal;
Eldin, Abeer Sharaf;
Hassan, Elham Ahmed;
Fakhry, Hussein;
Soliman, Ahmed;
El-Badawy, Omnia

Publication type:

Article